Trademark Overview
On Wednesday, April 22, 2020, a trademark application was filed for GASTROBIOME with the United States Patent and Trademark Office. The USPTO has given the GASTROBIOME trademark a serial number of 88883467. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, February 1, 2021. This trademark is owned by Leading BioSciences. The GASTROBIOME trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical formulations and preparations to treat acute and chronic health conditions related to gastrointestinal, inflammatory, metabolic, endocrine, immunological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, psychiatric, dermatological, and viral diseases and disorders; Pharmaceutical compositions in liquid form, namely, liquid compositions containing protease inhibitors, to treat health conditions, diseases, and disorders related to the gastrointestinal tract, gastrointestinal permeability, the gastrointestinal epithelial barrier, gastrointestinal inflammation, the gastrointestinal immune system, the microbiome, and the gut-brain axis; Pharmaceutical formulations and preparations to treat or prevent surgical complications and post-surgical complications; Pharmaceutical formulations and preparations to treat or prevent shock, namely, acute shock, cardiogenic shock, septic shock and hemorrhagic shock; Phar...
